Legal Representation
Attorney
Mark A. Nieds
USPTO Deadlines
Application History
24 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Feb 18, 2014 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
Feb 17, 2014 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Jul 16, 2013 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Jul 16, 2013 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
May 21, 2013 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
May 21, 2013 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
May 1, 2013 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Apr 15, 2013 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Apr 10, 2013 | ALIE | A | ASSIGNED TO LIE | Loading... |
Mar 20, 2013 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Mar 20, 2013 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Mar 20, 2013 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Mar 20, 2013 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Mar 20, 2013 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Mar 19, 2013 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Mar 18, 2013 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Mar 18, 2013 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Sep 25, 2012 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Sep 25, 2012 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Sep 25, 2012 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Sep 25, 2012 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jun 19, 2012 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED | Loading... |
Jun 18, 2012 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jun 12, 2012 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Active chemical ingredients for use in the manufacture of pharmaceuticals for treating pain, cough and upper respiratory symptoms, opioid addiction, behavioral disorders, diabetes, and prostate cancer; Excipients and chemical additives for use in the manufacture of pharmaceuticals and food; Chemicals for use in the manufacture of radiopharmaceuticals
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Pharmaceutical preparations for the treatment of pain, cough and upper respiratory symptoms, opioid addiction, insomnia, depression, and behavioral disorders; contrast media for use in medical imaging procedures; radiopharmaceutical preparations for use in nuclear medicine; Pharmaceutical kits for making radiopharmaceutical diagnostic preparations; syringes sold filled with saline solution
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Non-invasive power injectors used for subcutaneous injection of medicine and imaging solutions for medical imaging procedures and component parts therefor; Medical apparatus for warming contrast media; Medical generators for use in the production and transportation of nuclear medicine and component parts therefor; Radioaerosol generators, namely, nebulizers for administering radioactive medicine and imaging solutions in gaseous form for medical imaging procedures and component parts therefor; Elution shields, namely, nuclear medicine radiation apparatus for collection of sodium-pertechnetate from Mo99/ Tc99m generators and radiation shielding; Medical imaging apparatus and instruments in the field of urology, and component parts therefor
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the stylized word "MALLINCKRODT" appearing to the right of a three dimensional rectangular design containing interlocking triangular, square and cubical shapes forming the letter "M" in the foreground.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
001
005
010